Services

25 - 36 of 249 listings
Listings
  • Py8119

    Py8119

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    The P8119 cell line represents a mesenchymal tumor cell derived from a mammary adenocarcinoma that spontaneously arose in a MMTV-PyMY (mouse mammary tumor virus promoter driven Polyoma middle T-antigen) transgenic C57BL/6 female mouse. This cell line...

  • NMuMG

    NMuMG

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    Initiated from the mammary gland tissue of an adult NAMRU mouse and one of a series of epithelial cell lines derived from normal glandular tissue of mice. The cells exhibit many ultrastructural features of secretory epithelium as well as desmosomes o...

  • MS-5

    MS-5

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    Established by irradiation of the adherent cells in long-term bone marrow cultures derived from C3H/HeNSlc strain mice https://www.creative-bioarray.com/MS-5-CSC-C2763-item-1619.htm

  • NS20Y

    NS20Y

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    Established from a A/J mouse strain with neuroblastoma C1300; cells were described to be aneuploid and to contain high specific activity of choline acetyltransferase https://www.creative-bioarray.com/NS20Y-CSC-C1062-item-1530.htm

  • A20

    A20

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    Cat.No. CSC-C6292J Description Mouse cell line derived from lymphoma. Species Mus musculus (Mouse) Recommended Medium RPMI-1640 + 10% h.i. FBS https://www.creative-bioarray.com/a20-item-csc-c6292j-42892.htm

  • BA/F3

    BA/F3

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    IL-3 dependent murine pro B cell line; the precise origin of the cell line is unclear; however, performing May-Grünwald-Giemsa staining provides evidence that the cells are indeed from a lymphatic back ground. Cells were apparently not derived from B...

  • 32D

    32D

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    Established from long-term bone marrow cultures of C3H/HeJ mice infected with the Friend murine leukemia virus; cells are constitutively growth factor-dependent https://www.creative-bioarray.com/32D-CSC-C1101-item-1563.htm

  • WEHI 231

    WEHI 231

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    Cat.No. CSC-C9260W Description Mineral oil induced tumor in (BALB/c x NZB)F1 mice Species Mus musculus (Mouse) Recommended Medium DMEM + 0.05mM 2-Mercaptoethanol (2ME) + 10% Foetal Bovine Serum (h.i.FBS). https://www.creative-bioarray.com/WEHI-231-CS...

  • Hepa 1-clc7

    Hepa 1-clc7

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    Species: mouse, C57L; Tissue: liver; Tumor: hepatoma, BW7756; Derived from: Hepa-1cl, cloned from the Hepa-1 cell line https://www.creative-bioarray.com/Hepa-1-clc7-CSC-6264W-item-1508.htm

  • B16F10/mGM

    B16F10/mGM

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    Cat.No. CSC-C6409J Description Mouse GM-CSF producing B16 melanoma. Species Mus musculus (Mouse) Source Skin https://www.creative-bioarray.com/b16f10-mgm-item-csc-c6409j-43009.htm

  • B16 F10

    B16 F10

    Immunology Shirley (New York) September 30, 2026 1.00 Dollar US$

    Cat.No. CSC-C9336L Description established from the skin of C57BL/6J mouse with B16 melanoma tumor Species Mus musculus (Mouse) Source Skin https://www.creative-bioarray.com/b16-f10-csc-c9336l-item-39483.htm

  • B16 BL6

    B16 BL6

    Drug Development Shirley (New York) September 30, 2026 1.00 Dollar US$

    Cat.No. CSC-C9334L Description Histopathology: melanoma Species Mus musculus (Mouse) Source Skin https://www.creative-bioarray.com/B16-BL6-CSC-C9334L-item-39481.htm